Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy
- DOI
- 10.1007/s11030-026-11730-z
- Published
- 2026-09-25
- Container
- Molecular Diversity
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s11030-026-11730-z,
title = {Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy},
author = {Nashwa H. Zaher and Reham M. M. El-Hazek and Mohamed I. Mostafa},
year = {2026},
journal = {Molecular Diversity},
doi = {10.1007/s11030-026-11730-z},
url = {https://doi.org/10.1007/s11030-026-11730-z}
}RIS
TY - JOUR TI - Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy AU - Nashwa H. Zaher AU - Reham M. M. El-Hazek AU - Mohamed I. Mostafa PY - 2026 JO - Molecular Diversity DO - 10.1007/s11030-026-11730-z UR - https://doi.org/10.1007/s11030-026-11730-z ER -
APA
Zaher, N. H., El-Hazek, R. M. M., & Mostafa, M. I. (2026). Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy. Molecular Diversity. https://doi.org/10.1007/s11030-026-11730-z
Source records
- crossref · retrieved 2026-09-26T06:57:51.715Z